top of page
Wigard Kloosterman
Co-Founder & CEO
Wigard holds a PhD in Molecular Biology from Utrecht University and is a leading expert in genome sequencing technology. He was an Associate Professor at the University Medical Center Utrecht, focusing on cancer genomics and complex genomic variants. Dr. Kloosterman has significantly contributed to bringing cancer genomics research into clinical practice and is at the forefront of implementing Nanopore sequencing technology.
bottom of page